About Luca Vincenzo Cappelli
Post Doc at Weill Cornell Medicine. MD at Sapienza University, Rome.
Intro Content
Leukemia
Indeterminate and oncogenic potential: CHIP vs CHOP mutations in AML with NPM1 alteration
Deep sequencing of multiple AML-associated genes at disease milestones allows the classification of mutations, detection of molecular residual disease and identification of high-risk patients despite molecular remission in NPM1mut AML.